The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as two weeks. That may not leave enough time for the immune system to mount an effective response.
The goal of some anti-viral therapies, therefore, is to buy more and give the immune system a leg up on the virus. A new study demonstrates a way to do that, by reducing the ability of the virus to exit a host cell and spread. The work showed that blocking a calcium-signaling pathway could inhibit not only the Ebola virus, but also Marburg, Lassa and Junin viruses, all sources of deadly infections.
They conducted initial experiments using non-infectious viral-like particles, or VLPs, the production of which is orchestrated by the virus’ matrix protein and which bud from cells in a similar manner to the infectious virus. This allows for the observation of host-virus interactions without using dangerous live viruses.
Calcium signaling is a key regulator of many cell processes, and earlier studies by these authors had suggested that calcium was needed by these and other viruses. The researchers followed up by examining how cellular calcium levels responded when VLPs were being produced in cells. They found that virus matrix proteins triggered significant upticks in calcium levels, which were prevented when the researchers introduced a mutated version of a gene that encodes a calcium channel called ORAI1 into the host cells.
Next they looked directly at VLP production in normal cultured cells or cells with a mutation in ORAI1. Production of Ebola, Marburg, Lassa and Junin VLPs were all significantly lowered, as much as 100-fold, in the ORAI1 mutant cells, an indication that hemorrhagic fever virus budding relies on the ORAI1-dependent calcium signaling.
Further studies implicated another protein upstream from ORAI1, called STIM1, as also required to form VLPs. Suppressing expression of STIM1 in cultured cells caused VLP production to decline.
To see whether they could pharmacologically block VLP production in normal cells, the Penn researchers used three different ORAI1 inhibitors. Each substantially inhibited production of Ebola and Marburg VLPs.
http://www.upenn.edu/pennnews/news/penn-study-blocks-ebola-virus-budding-regulating-calcium-signaling
Edited
Latest News
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Mapping microbiome in metas…
By newseditor
Posted 22 Apr
Full-length mRNA packaged i…
By newseditor
Posted 22 Apr
Glucose-sensing mechanism t…
By newseditor
Posted 21 Apr
Other Top Stories
A protein in maintaining liver size and function revealed
Read more
How gut microbes fight flu
Read more
Neurons that control brain's body clock identified!
Read more
New botulinum neurotoxin discovered!
Read more
Protein-rich diet may help soothe inflamed gut
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Neuronal activity rapidly r…
By newseditor
Posted 22 Apr
A perspective on muscle phe…
By newseditor
Posted 22 Apr
Foxp1 suppresses cortical a…
By newseditor
Posted 22 Apr
Single-cell long-read seque…
By newseditor
Posted 22 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar